Literature DB >> 25633669

Dysregulation of T cell subsets in the pathogenesis of hypertension.

Songcang Chen1, Devendra K Agrawal.   

Abstract

Essential hypertension (EH) and its complications have had a severe impact on public health. However, the underlying mechanisms of the pathogenesis of EH remain largely unknown. Recent investigations, predominantly in rats and mice, have provided evidence that dysregulation of distinct functions of T lymphocyte subsets is a potentially important mechanism in the pathogenesis of hypertension. We critically reviewed recent findings and propose an alternative explanation on the understanding of dysfunctional T lymphocyte subsets in the pathogenesis of hypertension. The hypothesis is that hypertensive stimuli, directly and indirectly, increase local IL-6 levels in the cardiovascular system and kidney, which may promote peripheral imbalance in the differentiation and ratio of Th17 and T regulatory cells. This results in increased IL-17 and decreased IL-10 in perivascular adipose tissue and adventitia contributing to the development of hypertension in experimental animal models. Further investigation in the field is warranted to inform new translational advances that will promote to understand the pathogenesis of EH and develop novel approaches to prevent and treat EH.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633669      PMCID: PMC5643157          DOI: 10.1007/s11906-014-0521-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  81 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Authors:  Modar Kassan; Maria Galan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 4.  Immune mechanisms in hypertension.

Authors:  Carolina De Ciuceis; Claudia Rossini; Elisa La Boria; Enzo Porteri; Beatrice Petroboni; Alice Gavazzi; Annamaria Sarkar; Enrico Agabiti Rosei; Damiano Rizzoni
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-21

5.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

6.  Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury.

Authors:  Jing Shao; Masaomi Nangaku; Toshio Miyata; Reiko Inagi; Koei Yamada; Kiyoshi Kurokawa; Toshiro Fujita
Journal:  Hypertension       Date:  2003-05-27       Impact factor: 10.190

7.  Critical role of CXCL16 in hypertensive kidney injury and fibrosis.

Authors:  Yunfeng Xia; Mark L Entman; Yanlin Wang
Journal:  Hypertension       Date:  2013-09-23       Impact factor: 10.190

8.  Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.

Authors:  Lucia Mazzolai; Michel A Duchosal; Martine Korber; Karima Bouzourene; Jean François Aubert; Hiroyuki Hao; Veronique Vallet; Hans-R Brunner; Jürg Nussberger; Giulio Gabbiani; Daniel Hayoz
Journal:  Hypertension       Date:  2004-08-09       Impact factor: 10.190

9.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

Authors:  Barbara Coles; Ceri A Fielding; Stefan Rose-John; Jürgen Scheller; Simon A Jones; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more
  8 in total

1.  Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.

Authors:  Erin B Taylor; Jennifer M Sasser; Kenji J Maeda; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

2.  Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Authors:  Corbin A Shields; Maggie McCalmon; Tarek Ibrahim; Dakota L White; Jan M Williams; Babbette LaMarca; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-02       Impact factor: 3.619

Review 3.  Sex and gender differences in hypertensive kidney injury.

Authors:  Jennifer C Sullivan; Ellen E Gillis
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

4.  Vitamin D controls resistance artery function through regulation of perivascular adipose tissue hypoxia and inflammation.

Authors:  Christopher J Pelham; Elizabeth M Drews; Devendra K Agrawal
Journal:  J Mol Cell Cardiol       Date:  2016-07-01       Impact factor: 5.000

Review 5.  Sodium and Its Role in Cardiovascular Disease - The Debate Continues.

Authors:  Yee Wen Kong; Sara Baqar; George Jerums; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-23       Impact factor: 5.555

6.  Increased expression and functionality of the gap junction in peripheral blood lymphocytes is associated with hypertension-mediated inflammation in spontaneously hypertensive rats.

Authors:  Xin Ni; Xin-Zhi Li; Zhi-Ru Fan; Ai Wang; Hai-Chao Zhang; Liang Zhang; Li Li; Jun-Qiang Si; Ke-Tao Ma
Journal:  Cell Mol Biol Lett       Date:  2018-08-20       Impact factor: 5.787

7.  Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension.

Authors:  Julio C Fernández-Ruiz; Julia C Galindo-De Ávila; Margarita L Martínez-Fierro; Idalia Garza-Veloz; Alberto R Cervantes-Villagrana; Monica A Valtierra-Alvarado; Carmen J Serrano; Mariana H García-Hernández; José A Enciso-Moreno; Julio E Castañeda-Delgado
Journal:  J Diabetes Res       Date:  2019-12-12       Impact factor: 4.011

Review 8.  Deeper insight into the role of IL-17 in the relationship beween hypertension and intestinal physiology.

Authors:  Ze-Jun Yang; Tian-Tian Wang; Bo-Ya Wang; Han Gao; Cheng-Wei He; Hong-Wei Shang; Xin Lu; Ying Wang; Jing-Dong Xu
Journal:  J Inflamm (Lond)       Date:  2022-10-04       Impact factor: 6.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.